Molecule Protocol

molecule.to

Molecule is a software platform to accelerate innovation in the pharmaceutical industry. It connects scientists, patients and industry to advance drug development in a collaborative open market.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Research

TWO LABS, AN ENVISION PHARMA GROUP COMPANY ACQUIRES RIPARIAN

Two Labs | July 08, 2021

news image

Two Labs, an industry-leading pharma services company and a subsidiary of Envision Pharma Group, announced today the acquisition of Riparian, a pharma consulting and SaaS company that assists manufacturers with pricing regulations, reporting, strategies, and program operations. The acquisition expands Two Labs' pharma service offerings, allowing the company to offer greater insights into the financials associated with drug launch and management, better positioning manufacturer...

Read More

CHALLENGES FOR TRANSLATING PHARMACOMICROBIOMICS TO PERSONALIZED MEDICINE

News-Medical.Net | March 02, 2020

news image

A new Commentary identifies three actionable challenges for translating pharmacomicrobiomics to personalized medicine in 2020.Pharmacomicrobiomics is the study of how microbiome variations within and between individuals affect drug action, efficacy, and toxicity. This personalized medicine horizon scanning is featured in OMICS: A Journal of Integrative Biology, the peer-reviewed interdisciplinary journal published by Mary Ann Liebert, Inc., publishers. Ramy Aziz and Marwa ElRakaiby, Cairo Univer...

Read More

Pharma Tech

INVITAE TO ACQUIRE CIITIZEN TO STRENGTHEN ITS PATIENT-CONSENTED HEALTH DATA PLATFORM TO IMPROVE PERSONAL OUTCOMES AND GLOBAL RESEARCH

Invitae | September 07, 2021

news image

Invitae , a leading medical genetics company, today announced it has entered into a definitive agreement to acquire Ciitizen, a patient-centric consumer health tech company. Backed by a16z, Section 32 and Verily, Ciitizen is working to build a global platform to help patients collect, organize, store and share their medical records digitally. The acquisition would enhance Invitae's platform by providing patients an easy-to-use, centralized hub for their genomic and clinical information, whic...

Read More

Business Insights

MHRA EXPANDS RELATIONSHIP WITH COMMONWEALTH INFORMATICS TO TRANSFORM DRUG SAFETY

Commonwealth Informatics, a Genpact company | January 25, 2022

news image

Commonwealth Informatics, an independently-operated subsidiary of Genpact, and leading technology and services company with industry expertise in medical product safety and public health surveillance, today announced that it has expanded its relationship with the Medicines and Healthcare products Regulatory Agency, a medical regulatory body for the United Kingdom. MHRA has selected Commonwealth Informatics' state-of-the-art signal detection and signal management solution, Comm...

Read More
news image

Research

TWO LABS, AN ENVISION PHARMA GROUP COMPANY ACQUIRES RIPARIAN

Two Labs | July 08, 2021

Two Labs, an industry-leading pharma services company and a subsidiary of Envision Pharma Group, announced today the acquisition of Riparian, a pharma consulting and SaaS company that assists manufacturers with pricing regulations, reporting, strategies, and program operations. The acquisition expands Two Labs' pharma service offerings, allowing the company to offer greater insights into the financials associated with drug launch and management, better positioning manufacturer...

Read More
news image

CHALLENGES FOR TRANSLATING PHARMACOMICROBIOMICS TO PERSONALIZED MEDICINE

News-Medical.Net | March 02, 2020

A new Commentary identifies three actionable challenges for translating pharmacomicrobiomics to personalized medicine in 2020.Pharmacomicrobiomics is the study of how microbiome variations within and between individuals affect drug action, efficacy, and toxicity. This personalized medicine horizon scanning is featured in OMICS: A Journal of Integrative Biology, the peer-reviewed interdisciplinary journal published by Mary Ann Liebert, Inc., publishers. Ramy Aziz and Marwa ElRakaiby, Cairo Univer...

Read More
news image

Pharma Tech

INVITAE TO ACQUIRE CIITIZEN TO STRENGTHEN ITS PATIENT-CONSENTED HEALTH DATA PLATFORM TO IMPROVE PERSONAL OUTCOMES AND GLOBAL RESEARCH

Invitae | September 07, 2021

Invitae , a leading medical genetics company, today announced it has entered into a definitive agreement to acquire Ciitizen, a patient-centric consumer health tech company. Backed by a16z, Section 32 and Verily, Ciitizen is working to build a global platform to help patients collect, organize, store and share their medical records digitally. The acquisition would enhance Invitae's platform by providing patients an easy-to-use, centralized hub for their genomic and clinical information, whic...

Read More
news image

Business Insights

MHRA EXPANDS RELATIONSHIP WITH COMMONWEALTH INFORMATICS TO TRANSFORM DRUG SAFETY

Commonwealth Informatics, a Genpact company | January 25, 2022

Commonwealth Informatics, an independently-operated subsidiary of Genpact, and leading technology and services company with industry expertise in medical product safety and public health surveillance, today announced that it has expanded its relationship with the Medicines and Healthcare products Regulatory Agency, a medical regulatory body for the United Kingdom. MHRA has selected Commonwealth Informatics' state-of-the-art signal detection and signal management solution, Comm...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us